← Back to Clinical Trials
Recruiting NCT07147673

NCT07147673 fNIRS Grasping Task in Infants

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07147673
Status Recruiting
Phase
Sponsor University Ghent
Condition Preterm and Term Infants
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2022-09-26
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 3 Months
Max Age 9 Months
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2022-09-26 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the neural mechanisms involved in the development of reach-to-grasp function in infants. Reaching and grasping are crucial motor skills that develop early in infancy and are essential for later motor and cognitive milestones. Understanding how these skills emerge and the underlying neural processes can provide valuable insights into both typical and atypical development. The study will focus on infants aged 3 to 9 months, a critical period for the development of reach-to-grasp skills. A total of 100 infants will be recruited, including 50 full-term infants and 50 preterm infants (born \<36 weeks gestational age). Reach-to-grasp function will be evaluated through a cross-sectional assessment at a single time point. Functional near-infrared spectroscopy (fNIRS) will be used as the brain imaging technique to measure brain activity during the reach-to-grasp task. The use of fNIRS will allow for a non-invasive assessment of neural activity in real time, providing insights into the brain mechanisms supporting the development of motor skills. The findings may offer important information about the neural basis of motor development in infancy, particularly in the context of preterm birth.

Eligibility Criteria

Inclusion Criteria: * 3-9 months old * can tolerate the fNIRS cap * performs at least 2 grapsing attempts with one hand within one minute when prompting the hand with a toy Exclusion Criteria: * history of periferal neurological lesion such as plexus brachialis lesion * presence of epilepsia, congenital brain malformation, * no informed consent * severe visual impairments * syndromal or genetical diseases resulting into developmental delay

Contact & Investigator

Central Contact

Nele De Bruyn, Phd

✉ nele.debruyn@ugent.be

📞 00329 332 69 21

Principal Investigator

Nele De Bruyn, Phd

PRINCIPAL INVESTIGATOR

University Ghent

Frequently Asked Questions

Who can join the NCT07147673 clinical trial?

This trial is open to participants of all sexes, aged 3 Months or older, up to 9 Months, studying Preterm and Term Infants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07147673 currently recruiting?

Yes, NCT07147673 is actively recruiting participants. Contact the research team at nele.debruyn@ugent.be for enrollment information.

Where is the NCT07147673 trial being conducted?

This trial is being conducted at Ghent, Belgium.

Who is sponsoring the NCT07147673 clinical trial?

NCT07147673 is sponsored by University Ghent. The principal investigator is Nele De Bruyn, Phd at University Ghent. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology